Elhuyar Fundazioa Jun 4 2026 The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend of lipids and proteins that lines the alveoli and enables breathing), which are encapsulated in a drug used to treat pulmonary fibrosis . It was shown that these nanoparticles are highly capable of remaining trapped in the diseased tissue after being administered via the pulmonary pathway. This allows the doses of antifibrotic medication to